Analysis of Pmel17/gp100 expression in primary human tissue specimens: Implications for melanoma immuno- and gene-therapy

Cancer Immunology Immunotherapy

Volumn 44, Issue 4, 1997, Pages 239-247

  Wagner, Stephan N ^a   Wagner, Christine ^a   Schultewolter, Thomas ^a   Goos, Manfred ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Expression analysis; Immunotherapy; Melanoma; Phenotyping; Pmel17 gp100

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MELANOMA; PRIORITY JOURNAL; RETINA; SUBSTANTIA NIGRA;

ANTIBODIES, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, NORTHERN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; MELANOMA; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; NEVUS; PROTEINS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0030791579     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050379     Document Type: Article

References (46)

1. Adema GJ, Boer AJ de, Hullenaar R van't, Denijn M, Ruiter DJ, Vogel AM, Figdor CG (1993) Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Patliol 143:1579
2. Adema GJ, Boer AJ de, Vogel AM, Loenen WAM, Figdor CG (1994) Molecular characterization of the melanocyte lineage-specific antigen gp 100. J Biol Chem 269:20126
3. Bakker ABH, Schreurs MWJ, Boer AJ de, Kawakami Y, Rosenberg SA, Adema GJ, Fidgor CG (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179:1005
4. Bakker AB, Schreurs MW, Tafazzul G, Boer AJ de, Kawakami Y, Adema GJ, Figdor CG (1995) Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2. 1-restricted anti-melanoma CTL line. Int J Cancer 62:97
5. Bakker ABH. Marland G, Boer AJ de, Huijbens RJF, Danen EHJ, Adema GJ, Figdor CG (1995) Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 55:5330
6. Boel P. Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167
7. Bonetti F, Colombari R, Manfrin E, Zamboni G. Martignoni G, Mombello A, Chilosi M (1989) Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast. Am J Clin Pathol 92:491
8. Boon T (1992) Toward a genetic analysis of tumor rejection antigens. Adv Cancer Res 58:177
9. Boon T, Cerottini J-C, Eynde B van den, Bruggen P van der, Pel a van (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337
10. Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethe B, Coulie P, Boon T (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178:489
11. Cells E, Tsai V, Crimi C, DeMars R, Wentworth PA, Chesnut RW, Grey HM, Sette A, Serra HM (1994) Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA 91:2105
12. Chen L, Ashe S, Brady WA, Hellström I, Hellström KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093
13. Chirgwin JM, Przybyla AK, McDonald RJ, Rutter WJ (1979) Isolation of biologically active RNA from sources enriched in ribonuclease. Biochemistry 18:5294
14. Clark WH (1991) Tumour progression and the nature of cancer. Br J Cancer 64:621
15. Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP, Renauld JC, Boon T (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35
16. Coulie PG, Lehmann F, Lethe B, Herman J, Lurquin C, Andrawiss M, Boon T (1995) A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on an human melanoma. Proc Natl Acad Sci USA 92:7976
17. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff Jr. CL (1994) Identification of a peptide recognized by five different melanoma-specific human cytotoxic T cell lines. Science 264:716
18. Gaugler B, Eynde B van den, Bruggen P van der, Romero P, Gaforio JJ, De Plaen E, Lethe B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921
19. Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA (1986) Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 123:195
20. Jäger E, Ringhoffer M, Dienes HP, Arand M, Karhach J, Jäger D, Ilsemann C, Hagedorn M, Oesch F, Knuth A (1996) Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo, Int J Cancer 67:54
21. Kapur RP, Bigler SA, Skelly M, Gown AM (1992) Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem 40:207
22. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA (1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci 91:6458
23. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yanelli JR, Apella E, Rosenberg SA (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180:347
24. Kawakami Y, Eliyahu S, Jennings C, Sagakuchi K, Kang X, Southwood S, Robbins PF, Sette A, Appella E, Rosenberg SA (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T-lymphocytes associated with in vivo tumor regression. J Immunol 154:3961
25. Kwon BS, Halaban R, Kim GS, Usack L, Pomerantz S, Haq AK (1987) A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl-xanthine. Mol Biol Med 4:339
26. Leong AS, Millos J (1989) An assessment of a melanoma-specific antibody (HMB-45) and other immunahistochemical markers of malignant melanoma in paraffin-embedded tissues. Surg Pathol 2:137
27. Lu C, Kerbel RS (1994) Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma. Curr Opin Oncol 6:212
28. Melief CJM (1992) Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res 58:143
29. Moos M, Gallwitz D (1983) Structure of two human β-actin-related processed genes one of which is located next to a simple repetive sequence. KMBOJ 2:757
30. Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E, Rosenberg SA (1995) Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J Immunol 154:2257
31. Robbins PF, El-Glamil M, Li YF, Topalian SL, Rivoltini L, Sakaguchi K, Appella E, Kawakami Y, Rosenberg SA (1995) Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J Immunol 154:5944
32. Robbins PF, El-Glamil M, Li YF, Kawakami Y, Loftus D, Appella E, Rosenberg SA (1996) A mutated beta-catenin gene encodes a melanoma-speciffic antigen recognized by tumor infiltrating lymphocytes. J Exp Med 183:1185
33. Salgaller ML, Afshar A, Marincola FM, Rivoltini L, Kawakami Y, Rosenberg SA (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res 55:4972
34. Smoller BR, McNutt NS, Hsu A (1988) HMB-45 recognizes stimulated melanocytes. J Cutan Pathol 16:49
35. Smoller BR, Hsu A, Krueger J (1991) HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein. J Cutan Pathol 18:315
36. Stevens EJ, Jacknin L, Robbins PF, Kawakami Y, El-Gamil M, Rosenberg SA, Yannelli JR (1995) Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. J Immunol 154:762
37. Van den Eynde B, Peeters O, De Backer O, Gaugler B. Lucas S, Boon T (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182:689
38. Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De-Plaen E, Eynde B van den, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma. Science 254:1643
39. Van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boel P, De Smet C. Traversari C, Townsend A, Boon T (1994) A peptide encoded by human MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 24:3038
40. Vennegor C, Hagemann P, Nouhuijs H van, Ruiter DJ, Calafat J, Ringens PJ, Rümke P (1988) A monoclonal antibody specific for cells of the melanocytic lineage. Am J Pathol 130:179
41. Wagner SN, Wagner C, Höfler H, Atkinson MJ, Goos M (1995) Expression cloning of the cDNA encoding a melanoma-associated antigen recognized by monoclonal antibody HMB-45: identification as melanocyte-specific Pmell7 cDNA. Lab Invest 73:229
42. Wang RF, Robbins PF, Kawakami Y, Kang XQ, Rosenberg SA (1995) Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor infiltrating lymphocytes. J Exp Med 181:799
43. Wang RF, Appella E, Kawakami Y, Kang X, Rosenberg SA (1996) Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med 184:2207
44. Wölfel T, Pel A van, Brichard V, Schneider J, Seliger B, Meyer zum Büschenfelde KH, Boon T (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24:759
45. Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankein T, Meyer zum Büschenfelde KH, Beach D (1995) A p16ink4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281
46. Zhai Y, Yang JC, Kawakami Y, Spiess P, Wadsworth SC, Cardoza LM, Couture LA, Smith AK, Rosenberg SA (1996) Antigen specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART-1 or gp100 for cancer therapy. J Immunol 156:700